MedPath

Understanding and Helping Families: Parents With Psychosis

Not Applicable
Conditions
Psychosis
Schizophrenia
Parenting
Interventions
Behavioral: Triple P Positive Parenting Programme
Registration Number
NCT02622048
Lead Sponsor
University of Manchester
Brief Summary

The purpose of this trial is to explore parent-child interactions in parents with and without psychosis, and ascertain whether a brief (10 week) supported self-help parenting program offered to parents in their own homes can help improve parents' self-efficacy and general well-being, as well as interpretations of their parent-child relationship and child behaviour in children who are 3-10 years old.

Detailed Description

The trial will be split into two stages.

Stage 1: Parents with no history of serious mental health problems and parents who have a history of psychosis or schizophrenia, who have children aged 3-10 years old, will take part in the Revised Five Minute Speech Sample (FMSS) and the Modified Camberwell Family Interview (CFI). They will also complete various measures looking at parental well-being, depression, anxiety and stress as well as parenting behaviours and interpretations of their child behaviour. In addition the PANSS interview will also be used. These interviews will be coded to investigate attributional patterns.

Stage 2: Parents who are experiencing psychosis, who took part in stage 1 will proceed to stage 2 if they want to. Parents will be seen weekly and take part in a guided self-help parenting intervention. This will require weekly visits over 10 weeks to the parents. During this time, symptoms, mood, general well-being and parenting behaviours will be monitored.

There will be no randomisation: all parents experiencing psychosis will receive the intervention.

Children do not attend the sessions, but it is hoped that parents practice the skills learned.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Stage 2 Parents experiencing psychosisTriple P Positive Parenting ProgrammeParents all receive the self-directed Triple P Positive Parenting Programme
Primary Outcome Measures
NameTimeMethod
Positive and Negative Syndrome Scale (PANSS)Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up

Assessment of parental symptoms, mood, behaviours, aswell as social performance and depression

Five Minute Speech Sample (FMSS)Initial Ax, End Ax, Follow up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up

Assessment of Expressed Emotion using a 5 minute uninterrupted interview

Modified Camberwell Family Interview (CFI)Initial Ax only

In depth assessment of Expressed Emotion using a modified version of the CFI. This version is for parents of well children.

Secondary Outcome Measures
NameTimeMethod
Depression, Anxiety and Stress Scale (DASS-21)Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up

Self-reported depression, anxiety and stress using a short form scale

Warwick-Edinburgh Mental Well-being Scale (WEMWBS)Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up

Self-reported general well-being

Parenting and Family Adjustment Scale (PAFAS)Baseline, 1, 5, 10, follow up

An assessment of parenting skills and family relationships.

Eyberg Child Behaviour Inventory (ECBI)Initial Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up

Parents self-reported child problem behaviour

Strengths and Difficulties Questionnaire (SDQ)Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up

Parents self-reported child behaviour assessing different aspects of behaviour, e.g.,: emotional symptoms, conduct problems, hyperactivity/inattention.

Trial Locations

Locations (1)

The University of Manchester

🇬🇧

Manchester, Lancashire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath